Axcella Health Inc. Common Stock
AXLA
AXLA was delisted on the 22nd of November, 2023.
15 hedge funds and large institutions have $17.1M invested in Axcella Health Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 15 closing their positions.
1,118% more call options, than puts
Call options by funds: $609K | Put options by funds: $50K
64% more capital invested
Capital invested by funds: $10.5M → $17.1M (+$6.68M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
46% less funds holding
Funds holding: 28 → 15 (-13)
75% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 8
87% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$791K |
| 2 |
JP Morgan Chase
New York
|
+$8.44K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.71K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$551 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.71M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$43.7K |
| 3 |
Edgewood Management
Greenwich,
Connecticut
|
-$21.8K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$19.8K |
| 5 |
State Street
Boston,
Massachusetts
|
-$16.9K |
AXLA Hedge Fund Activity: Q3 2023 in Review
15 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q3 2023, worth a combined $17.1M — up 64% from $10.5M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of AXLA and 2 opened new positions — a net loss of 13 holders — while 8 trimmed existing stakes and 2 added.
The largest buyer was Schonfeld Strategic Advisors, opening a new position worth an estimated $791K. The largest seller was Fidelity Investments, cutting an estimated $2.71M.
- 15 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q3 2023, down from 28 in Q2 2023.
- Funds reported $17.1M of Axcella Health Inc. Common Stock stock for Q3 2023, up 64% quarter-over-quarter.
- 2 funds opened new Axcella Health Inc. Common Stock positions in Q3 2023 and 15 closed out, a net change of -13 holders.
- The largest Axcella Health Inc. Common Stock buyer in Q3 2023 was Schonfeld Strategic Advisors, an estimated $791K added.
- The largest Axcella Health Inc. Common Stock seller in Q3 2023 was Fidelity Investments, an estimated $2.71M sold.
Based on aggregated 13F filings for Q3 2023.